Abstract
Schistosomiasis is caused by infection with blood flukes of the genus Schistosoma, of which three species (S. mansoni, S. hematobium, and S.japonicum) are the principal causes of disease in man. Schistosomiasis is a major health problem in the developing world, with an estimated 200 million persons infected and 600 million living in endemic areas where they are at risk of infection of (BERGQUIST 1987). This helminth parasite is acquired by man or other mammalian hosts through contact with a larval form found in fresh water. Having penetrated the skin, the larvae migrate and mature into adult worms living in the veins of the intestinal or urinary tract. Paired male and female worms produce hundreds to thousands of eggs per day, which are either excreted or become trapped in the body tissues of the host. Schistosomiasis is primarily a chronic disease, the pathology of which is associated with reaction to these trapped eggs. However the estimated mortality rate of approximately 1% (BERGQUIST 1987) translates into hundreds of thousands of lives lost annually.
The ongoing research described here is supported in part by grants from the Edna McConnell Clark Foundation and the World Health Organization
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bergquist R (1987) Schistosomiasis. In: Tropical disease research, a global partnership. Eighth programme report of the UNDP/World Bank/WHO special programme for research and training in tropical diseases. World Health Organization, Geneva.
Butterworth AE, Hagan P (1987) Immunity in human schistosomiasis. Parasitol Today 3: 11–16.
Capron A, Dessaint JP, Capron M, Ouma JH, Butterworth AE (1987) Immunity to schistosomes: progress toward vaccine. Science 23: 1065–1072.
Coffman RL, Seymour B, Lebman D, Hirak D, Christiansen J, Shrader B, Cherwinski H, Savelkoul H, Finkelman F, Bond M, Mosmann T (1988) The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 102: 5–28.
Colley DG (1981) Immune responses and immunoregulation in experimental and clinical schistosomiasis. In: Mansfield JM (ed) The immunology of parasitic disease. Dekker, New York.
Correa-Oliveira R, Sher A, James SL (1984) Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. I. Analysis of antibody responses. J Immunol 133: 1581–1586.
Crabtree JE, Wilson RA (1986) The role of pulmonary cellular reactions in the resistance of vaccinated mice to Schistosoma mansoni. Parasite Immunol 8: 265.
Crawford F, Finbloom D, Ohara J, Paul W, Meltzer MS (1987) B cell stimulatory factor 1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J Immunol 139: 135–141.
Gajewski TF, Fitch FW (1988) Anti-proliferative effect of IFN-gamma in immunoregulation. I. IFN-gamma inhibits the proliferation of TH 2 but not TH l murine helper T lymphocyte clones. J Immunol 140: 4245–4251.
Greene MI, Benacerraf B (1980) Studies on hapten specific T cell immunity and suppression. Immunol Rev 50: 163–186.
Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169: 59–72.
James SL (1985) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine is dependent on the method of antigen presentation. J Immunol 134: 1956–1960.
James SL (1986a) Activated macrophages as effector cells of protective immunity to schistosomiasis. Immunol Res 5: 139–148.
James SL (1986b) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages. J Immunol 136: 3872–3877.
James SL, DeBlois L (1986) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects. J Immunol 136: 3864–3871.
James SL, Sher A (1983) Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. III. Identification of a mouse strain, P/N, that fails to respond to vaccination. Parasite Immunol 5: 567–575.
James SL, Correa-Oliveira R, Leonard EJ (1984a) Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses. J Immunol 133: 1587–1593.
James SL, Natovitz PC, Farrar WL, Leonard EJ (1984b) Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae. Infect Immun 44: 569–575.
James SL, Pearce EJ, Sher A (1985) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts. J Immunol 134: 3432–3438.
James SL, Correa-Oliveira R, Sher A, Medvitz L, McCall RD (1987) Genetic association of defects in macrophage larvacidal activity and vaccine-induced resistance to Schistosoma mansoni in P strain mice. Infect Immun 55: 1884–1889.
James SL, Salzman C, Pearce EJ (1988) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. VI. Antigen recognition by nonresponder mouse strains. Parasite Immunol 10: 71–83.
Kelly EA, Colley DG (1988) In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. J Immunol 140: 2737–2745.
Lammie PJ, Michael AI, Linette GP, Phillips SM (1986a) Production of a fibroblast-stimulating factor by Schistosoma mansoni antigen-reactive T cell clones. J Immunol 136: 1100–1106.
Lammie PJ, Phillips SM, Linette GP, Michael AI, Bentley AG (1986b) In vitro granuloma formation using defined antigenic nidi. Ann N Y Acad Sci 465: 340–350.
Lanar D, Pearce EJ, James SL, Sher A (1986) Identification of paramyosin as the schistosome antigen recognized by intradermally vaccinated mice. Science 234: 593–596.
Mangold BL, Dean DA (1986) Passive transfer with serum and IgG antibodies of irradiated cercariae-induced resistance against Schistosoma mansoni in mice. J Immunol 136: 2644–2648.
Pearce EJ, James SL, Dalton J, Barrali A, Ramos C, Strand M, Sher A (1986) Immunochemical characterization and purification of SM-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol 137: 3593–3600.
Pearce EJ, James SL, Hieny S, Lanar D, Sher A (1988) Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a non-surface parasite antigen. Proc Nat Acad Sci USA 85: 5678–5682.
Phillips SM, Lammie PJ (1986) Immunopathology of granuloma formation and fibrosis in schisto-somiasis. Parasitol Today 2: 296–302.
Phillips SM, DiConza J, Gold J, Reid W (1977) Schistosomiasis in the congenitally athymic (nude) mouse. I. Thymic dependency of eosinophilia, granuloma formation and host morbidity. J Immunol 118: 594–599.
Scott P, Natovitz P, Coffman R, Pearce EJ, Sher A (1988) Immunoregulation of cutaneous leishmaniasis: T cell lines which transfer protective immunity or exacerbation belong to different TH subsets and respond to distinct parasite antigens. J Exp Med 168: 1675–1684.
Sher A, McIntyre S, von Lichtenberg F (1977) Kinetics and class specificity of hypergammaglobulinemia induced during murine infection. Exp Parasitol 41: 415–422.
Sher A, Hieny S, James SL, Asofsky R (1982) Mechanisms of protective immunity against Schistosoma mansoni in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes and complement. J Immunol 128: 1880–1884.
Sher A, Pearce EJ, Hieny S, James SL (1986) Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. IV. Fractionation and antigenic properties of a soluble adult worm immunoprophylactic activity. J Immunol 136: 3878–3883.
Smithers SR, Doenhoff MJ (1982) Schistosomiasis. In: Immunology of parasitic diseases. Blackwell, Oxford.
Stout R, Bottomly K (1988) Antigen-specific activation of effector macrophages by IFN-γ producing (TH 1) T cell clones. J Immunol 142: 760–765.
Ward R, McLaren DJ (1988) Schistosoma mansoni: evidence that eosinophils and/or macrophages contribute to skin phase challenge attrition in the vaccinated CBA/Ca mouse. Parasitology 96: 63–70.
Warren KS, Domingo EO, Cowan R (1967) Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol 51: 735–745.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
James, S.L., Sher, A. (1990). Cell-Mediated Immune Response to Schistosomiasis. In: Kaufmann, S.H.E. (eds) T-Cell Paradigms in Parasitic and Bacterial Infections. Current Topics in Microbiology and Immunology, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74983-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-74983-4_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74985-8
Online ISBN: 978-3-642-74983-4
eBook Packages: Springer Book Archive